Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-009630

EVP, Chief Financial Officer acquired 6,629 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kalif Eliyahu Sharon · EVP, Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-13 Exercise or conversion : show line 1 in the form +6,629 25,059 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-13 Exercise or conversion : show line 2 in the form Restricted Share Units −6,629 13,259 D
Loading xslF345X03/doc4.xml…